UroGen Pharma Ltd.
DE ˙ DB ˙ IL0011407140
23,18 € ↑0,82 (3,67%)
2026-06-05
PREZZO DELLE AZIONI
SecurityDE:UR8 / UroGen Pharma Ltd.
InstitutionCitigroup Inc
Latest Disclosed Ownership4,943 shares
Latest Disclosed Value $ 88,875
Citigroup Inc reports 45.30% increase in ownership of UR8 / UroGen Pharma Ltd.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 4,943 shares of UroGen Pharma Ltd. (DE:UR8) valued at $72,168 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 3,402 shares of UroGen Pharma Ltd.. This represents a change in shares of 45.30% during the quarter. The current value of the position is $114,579 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F UROGEN PHARMA COM M96088105 4,943 1,541 45.30 89 11.39 0.0000
2026-02-13 2025-12-31 13F UROGEN PHARMA COM M96088105 3,402 -1,291 -27.51 80 -15.05 0.0000
2025-11-10 2025-09-30 13F UROGEN PHARMA COM M96088105 4,693 -380,198 -98.78 94 -98.24 0.0000
2025-08-11 2025-06-30 13F UROGEN PHARMA COM M96088105 384,891 355,614 1,214.65 5,273 1,532.51 0.0026
2025-05-12 2025-03-31 13F UROGEN PHARMA COM M96088105 29,277 -8,733 -22.98 324 -20.05 0.0002
2025-02-12 2024-12-31 13F UROGEN PHARMA COM M96088105 38,010 9,882 35.13 405 13.17 0.0002
2024-11-12 2024-09-30 13F UROGEN PHARMA COM M96088105 28,128 19,796 237.59 357 156.83 0.0002
2024-08-12 2024-06-30 13F UROGEN PHARMA COM M96088105 8,332 3,494 72.22 140 93.06 0.0001
2024-05-10 2024-03-31 13F UROGEN PHARMA COM M96088105 4,838 -13,846 -74.11 73 -74.29 0.0000
2024-02-09 2023-12-31 13F UROGEN PHARMA COM M96088105 18,684 18,278 4,501.97 280 5,500.00 0.0002
2023-12-06 2023-09-30 13F/A-1 UROGEN PHARMA COM M96088105 406 -5,818 -93.48 6 -92.19 0.0000
2023-11-09 2023-09-30 13F UROGEN PHARMA COM M96088105 406 -5,818 6 0.0000
2023-08-10 2023-06-30 13F UROGEN PHARMA COM M96088105 6,224 -48,686 -88.67 64 -87.38 0.0000
2023-05-11 2023-03-31 13F UROGEN PHARMA COM M96088105 54,910 295 0.54 507 4.75 0.0004
2023-02-09 2022-12-31 13F UROGEN PHARMA COM M96088105 54,615 54,284 16,400.00 484 16,033.33 0.0004
2022-11-10 2022-09-30 13F UROGEN PHARMA COM M96088105 331 -410 -55.33 3 -50.00 0.0000
2022-08-10 2022-06-30 13F UROGEN PHARMA COM M96088105 741 -486 -39.61 6 -45.45 0.0000
2022-05-12 2022-03-31 13F UROGEN PHARMA COM M96088105 1,227 -4,385 -78.14 11 -79.25 0.0000
2022-02-10 2021-12-31 13F UROGEN PHARMA COM M96088105 5,612 2,169 63.00 53 -8.62 0.0000
2021-11-10 2021-09-30 13F UROGEN PHARMA COM M96088105 3,443 1,138 49.37 58 65.71 0.0000
2021-08-10 2021-06-30 13F UROGEN PHARMA COM M96088105 2,305 574 33.16 35 2.94 0.0000
2021-05-13 2021-03-31 13F UROGEN PHARMA COM M96088105 1,731 -2,695 -60.89 34 -57.50 0.0000
2021-02-11 2020-12-31 13F UROGEN PHARMA COM M96088105 4,426 2,173 96.45 80 86.05 0.0000
2020-11-12 2020-09-30 13F UROGEN PHARMA COM M96088105 2,253 -4,751 -67.83 43 -76.50 0.0000
2020-08-12 2020-06-30 13F UROGEN PHARMA COM M96088105 7,004 245 3.62 183 51.24 0.0001
2020-05-12 2020-03-31 13F UROGEN PHARMA COM M96088105 6,759 1,376 25.56 121 -32.78 0.0001
2020-02-12 2019-12-31 13F UROGEN PHARMA COM M96088105 5,383 3,881 258.39 180 414.29 0.0001
2019-11-08 2019-09-30 13F UROGEN PHARMA COM M96088105 1,502 -4,230 -73.80 35 -83.01 0.0000
2019-08-12 2019-06-30 13F UROGEN PHARMA COM M96088105 5,732 5,424 1,761.04 206 1,772.73 0.0002
2019-05-13 2019-03-31 13F UROGEN PHARMA COM M96088105 308 308 11 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.